Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, TDS

One Drop Announces Blood Glucose Prediction and Automated Decision Support


NEW YORK, June 23, 2018 /PRNewswire/ -- One Drop, a leader in the development of digital therapeutics solutions for people with diabetes, today announced the launch of Blood Glucose Prediction and Automated Decision Support. Through these new features, the One Drop | Mobile app will provide users: (1) blood glucose "forecasts" up to 12 hours into the future; and (2) behavioral recommendations based on those forecasts, thereby empowering users to manage diabetes proactively and reduce the risk complications.

One Drop is a fully integrated diabetes management platform right on your mobile phone (PRNewsfoto/One Drop)

Through One Drop's predictive analytic capabilities, people with diabetes will now be able to receive actionable insights into how their behavior (diet, physical activity, etc.) affects their blood glucose levels, without any intervention from a health care provider. The app will simply display insights for the user as they become relevant.

Blood glucose predictions come from One Drop's machine learning models, which are powered by over 1.1 billion data points collected by more than 860,000 One Drop | Mobile app users worldwide. Importantly, One Drop's models do not require getting to know an individual over time. Unlike other predictive tools, One Drop's models provide accurate predictions for one person based on the aggregate data of all people with similar health profiles. Within minutes of entering a single data point into the One Drop app, a user can receive their first prediction.

Data presented this week at the 78th American Diabetes Association's (ADA) Scientific Sessions show the models accurately predict future blood glucose values with 91% of predictions within +/- 50 mg/dL of glucometer readings and 75% within +/- 27 mg/dL. Overall accuracy improves as more data is fed to the machine learning models, and the accuracy for any given individual improves as he/she enters more personal health data into the app.

Blood Glucose Predictions and Automated Decision Support will launch for people with type 2 diabetes who are not on insulin within 90 days. For insulin users, these features are expected to launch soon thereafter.

"For every person using an insulin pump there are almost 500 who aren't, half of which aren't using insulin at all. The largest group with the biggest potential for shift in outcomes is the least supported by technology," said Dr. Dan Goldner, VP of Data Science Operations at One Drop. "The only way to get quality care and support to 500 million people is by developing inexpensive technology that gives each user exactly the support he or she needs, when it's needed. That's One Drop."

Population-level insights gathered from the machine learning models will also support One Drop's digitally-delivered coaching programs: One Drop | Experts, the first and only digitally-delivered diabetes education and coaching program recognized by the ADA, and One Drop | Revive, a new digitally-delivered diabetes prevention program expected to launch later this year (CDC recognition pending).

The One Drop digital therapeutics solution is uniquely positioned to improve outcomes for all. "Our mission at One Drop is to relentlessly improve and empower the lives of ALL people with diabetes through award winning consumer experiences, superior clinical efficacy, and automated decision support," said One Drop CEO, Jeff Dachis. "The medical system can't be there 24/7. But, One Drop can."

ABOUT ONE DROP

One Drop (Informed Data Systems, Inc.) is a digital health company harnessing the power of mobile computing and data science to transform the lives of everyone with diabetes worldwide.
The One Drop platform is evidence-based, clinically effective, and brings affordable, accessible diabetes care to everyone with diabetes and a smartphone. Learn more at http://www.onedrop.today/

SOURCE One Drop


These press releases may also interest you

at 02:00
Startup Creasphere, the first digital health innovation hub in Europe, has today announced a partnership with the consumer healthcare business unit of Sanofi. Sanofi will partner with Startup Creasphere and other companies in creating the ultimate...

at 02:00
X-BOLT® Revolutionary Hip Fracture Device Granted FDA 510k Approval X-Bolt Orthopaedics, a leading medical device company, today announced the 1000th patient has completed one-year of follow-up in the (n= 1,140 patients) multi-centre randomised...

at 02:00
Pendulum, LLC and the Long Term Care (LTC) Risk Legal Forum are proud to announce the continuation of the LTC Power Lawyers program. Nominations for its Class of 2019 are now being accepted. Now in its third year, LTC Power Lawyers is a...

at 02:00
Women's Excellence hosts first radio show on Detroit's WJR 760AM called the "Healthy Woman" Show. The "Healthy Woman" show airs on the second and third Wednesday of each month at 7pm. The third Wednesday is hosted by Women's Excellence Obstetrics and...

at 01:09
NEXT Biometrics (Oslo Bors: NEXT), a global leader in fingerprint sensor technology, today announced that it will start sampling its dual interface smart card solution (One Touch Flex CL) early in the second quarter of 2019. The solution enables...

at 01:00
Last night, the winners of the inaugural Irish Women's Awards Ireland were unveiled at a gala ceremony in the Crowne Plaza Dublin Blanchardstown Hotel. The awards ceremony welcomed over 200 guests and served to showcase...



News published on 23 june 2018 at 13:30 and distributed by: